n/a
Article Publish Status: FREE
Abstract Title:

Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose-Effect Relationships in an ExperimentalModel of Osteoarthritis.

Abstract Source:

Front Pharmacol. 2019 ;10:1347. Epub 2019 Nov 14. PMID: 31798452

Abstract Author(s):

Angela D'Ascola, Natasha Irrera, Roberta Ettari, Alessandra Bitto, Giovanni Pallio, Federica Mannino, Marco Atteritano, Giuseppe M Campo, Letteria Minutoli, Vincenzo Arcoraci, Violetta Squadrito, Giacomo Picciolo, Francesco Squadrito, Domenica Altavilla

Article Affiliation:

Angela D'Ascola

Abstract:

Drug combination is widely used to treat chronic inflammatory diseases. A similar strategy might be worth of interest to design plant-derived natural products to treat inflammatory conditions. Curcumin is a natural phenolic compound which shares anti-inflammatory activity with both flavocoxid, a flavonoid mixture of baicalin and catechin, andβ-caryophyllene, a bicyclic sesquiterpene. The aim of this study was to investigate the synergy potential of curcumin with both flavocoxid and β-caryophyllene in human articular chondrocytes triggered with lipopolysaccharide (LPS), in an experimentalmodel of osteoarthritis.Human articular chondrocytes were stimulated with LPS alone or in combination with different treatments. Total RNA was extracted 4 h after treatment to study interleukin 1β (IL-1β), NF-κB, and STAT3 mRNA expression. A drug combination study was designed choosing 5 doses to demonstrate a synergistic effect of compounds, according to Chou and Talalay method. A median-effect equation was applied and finally, the combination index (CI) was used to clarify the nature of the compounds interaction (synergistic versus additive versus antagonistic inhibitory effects); CI<1, CI = 1, and CI>1 indicated synergistic, additive, and antagonistic effects, respectively.LPS prompted IL-1β expression. Curcumin, flavocoxid and β-caryophyllene suppressed IL-1β expression with different IC. A synergistic action for the reduction of the inflammatory phenotype in human chondrocytes was observed for the combination curcumin-flavocoxid with a percentage from 10% to 90%, and for the combination curcumin-β-caryophyllene from 50% to 90%. ICdoses of either flavocoxid,β-caryophyllene and curcumin alone or in combination were safe and did not affect cell vitality. Moreover, the same ICdoses reduced the transcription factors NF-κB and STAT3 mRNA expression and interestingly the effects of the combinations were greater than the natural products alone, thus suggesting that the site where the synergy takes place could be at the signal transduction level.The results suggest that curcumin synergizes with either flavocoxid orβ-caryophyllene, exerting an anti-inflammatory activity and thus strongly suggesting the potential of a dual combination of these compounds for the management of osteoarthritis and unmasking a new feature of these natural products.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.